Tamoxifen Citrate (Nolvadex) is a Selective Estrogen Receptor Modulator (SERM) widely utilized in Post Cycle Therapy (PCT). It selectively binds to estrogen receptors in mammary tissue to prevent gynecomastia while stimulating endogenous LH and FSH secretion.
Key Benefits
- Gynecomastia Prevention: Blocks estrogenic action in breast tissue.
- HPTA Recovery: Stimulates pituitary release of LH and FSH to restart testosterone production.
- Lipid Profile Support: Maintains favorable HDL/LDL balance during PCT.
